Open AccessMale breast cancer diagnosis stages, treatment and survival in Uruguay: a retrospective analysis of a case series
Author(s) -
Natalia Camejo,
Cecilia Castillo,
Andrea Schiavone,
Ana Laura Alfonso,
Dahiana Amarillo,
Franco Xavier,
E. Álvarez,
Gabriel Krygier,
Lucı́a Delgado
Publication year - 2021
Publication title -
breast cancer management
Language(s) - English
Resource type - Journals
eISSN - 1758-1931
pISSN - 1758-1923
DOI - 10.2217/bmt-2020-0035
Subject(s) - medicine , male breast cancer , breast cancer , tamoxifen , stage (stratigraphy) , oncology , radiation therapy , chemotherapy , cancer , retrospective cohort study , disease , adjuvant chemotherapy , adjuvant , gynecology , paleontology , biology
Male breast cancer (MBC) is a rare condition which, while sharing some similarities with breast cancer in women, has a unique disease profile of its own. Aim: To understand the characteristics of MBC and its management in Uruguay. Patients & methods: Retrospective observational study that included patients diagnosed with MBC. Results: 22 cases of MBC were found. The median age at diagnosis was 62.5 years. Symptoms included self-detected lump in 17 patients (77.3%) and nipple retraction in seven (22.7%). Ductal carcinomas of histological grade 2–3 were found in 20 patients (90.9%) and stage I–II disease was most commonly encountered (15 patients, 68.1%). Neoadjuvant chemotherapy, adjuvant chemotherapy, adjuvant radiotherapy and tamoxifen were offered to 16 (73%), 12 (54.5%), 17 (65.4%) and 20 (90.9%) patients, respectively. Conclusion: MBC behaves and is treated in many aspects like postmenopausal breast cancer. Further multi-institutional, prospective studies are needed for better understanding and management of male breast cancers.